Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16548119 | 0.92 | LOX (0.35) | ALDH1A1 | |
| SCHEMBL26601375 | 0.90 | ALDH1A1 (0.33) | HRH3ALDH1A1 | |
| SCHEMBL27335545 | 0.90 | ALDH1A1 (0.33) | HRH3ALDH1A1 | |
| SCHEMBL2363137 | 0.88 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL16544487 | 0.86 | KDM1A (0.30) | HRH3 | |
| SCHEMBL26124636 | 0.82 | — | — | |
| SCHEMBL16548117 | 0.81 | MEN1 (0.39) | ALDH1A1 | |
| SCHEMBL9501290 | 0.81 | TSHR (0.40) | HRH3ALDH1A1 | |
| SCHEMBL6160683 | 0.81 | TSHR (0.40) | HRH3ALDH1A1 | |
| SCHEMBL6160680 | 0.81 | TSHR (0.40) | HRH3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180170896-A1 | METHODS OF PREPARING OXA-BICYCLOALKENE | INT FLAVORS & FRAGRANCES INC (US) | 2018-06-21 | — | — | US | disclosed |
| US-20180170896-A1 | METHODS OF PREPARING OXA-BICYCLOALKENE | INT FLAVORS & FRAGRANCES INC (US) | 2018-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180170896-A1 | METHODS OF PREPARING OXA-BICYCLOALKENE | OTC, AOC2, AOC3 | HRH3 2442/4885ALDH1A1 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.